NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
3.730
-0.100 (-2.61%)
At close: May 12, 2026, 4:00 PM EDT
3.800
+0.070 (1.88%)
After-hours: May 12, 2026, 4:50 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $302.68 million as of May 12, 2026. Its market cap has increased by 97.64% in one year.
Market Cap
302.68M
Enterprise Value
291.85M
1-Year Change
97.64%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $302.68M, an increase of 708.66%. That is a compound annual growth rate of 34.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 309.97M | -30.46% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 326.48M |
| Bicycle Therapeutics | 324.49M |
| Abeona Therapeutics | 322.81M |
| Achieve Life Sciences | 318.91M |
| Silence Therapeutics | 312.69M |
| Niagen Bioscience | 304.88M |
| Eledon Pharmaceuticals | 301.21M |
| Zentalis Pharmaceuticals | 301.12M |